Viewing Study NCT01332266


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-02-02 @ 6:20 PM
Study NCT ID: NCT01332266
Status: COMPLETED
Last Update Posted: 2022-01-03
First Post: 2011-04-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Sponsor: Eisai Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None head and neck View
None squamous cell carcinoma of the head and neck View
None phase 1b View
None phase 2 View